| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.05 |